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Core-sheath nanofibers were successfully prepared via coaxial electrospinning by using chitosan with
well-defined structural characteristics as the shell layer and poly (vinyl alcohol) (PVA) containing tetra-
cycline hydrochloride (TH) as the core layer. The effects of the average degree of deacetylation (DD) of
chitosan and the post-electrospinning genipin crosslinking on physicochemical and biological properties
of resulting nonwovens were evaluated. Defect-free and geometrically uniform nanofibers with diame-
ters predominantly in the range of 100–300 nm were prepared, and transmission electron microscopy
(TEM) revealed the core-sheath structures and its preservation after crosslinking. The mechanical prop-
erties, as well as the stability of nonwovens in aqueous medium, were greatly improved by genipin-
crosslinking, which enabled a sustained release of TH over 14 days. Results also revealed that the release
profile of TH in the presence of lysozyme was affected by the composition of the shell layer, as the TH
release rate increases with decreasing of DD. Further in vitro antimicrobial activity demonstrated that
the cross-linked nonwovens containing TH showed strong activity against bacterial strains associated
with periodontal disease. Additionally, the nonwovens did not demonstrate cytotoxic toward fibroblast
(HDFn) cells, hence showing their potential for applications as a novel drug delivery platform for peri-
odontitis treatment.
 2019 Elsevier B.V. All rights reserved.1. Introduction destruction of periodontal tissue, including the gingiva, periodon-Periodontitis is an inflammatory disease caused by dental pla-
que biofilm in the oral cavity that can lead to the progressivetal ligament (PDL), cementum, and alveolar bone [1–3]. Different
approaches for treating the periodontal tissues damaged by peri-
odontitis have been pursued including the so-called guided tissueTR-FTIR,
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application of a barrier membrane between the gingival epithelium
and connective tissues, which prevents migration of the epithe-
lium and gingival connective tissue cells into the defect sites and
provides a secluded space for the formation of PDL, cementum
and bone [4–6].
According to their degradation profile, GTR membranes are
classified into non-resorbable and resorbable, where the latter
are more advantageous once they can suppress a second surgical
procedure for membrane removal. Collagen-based GTR mem-
branes have demonstrated favorable results due to their excellent
biocompatibility, although its use presents some disadvantages
such as lack of control on the resorption rate and risk of disease
transmission [2,7,8].
Antimicrobial agents are frequently administrated to prevent/
treat bacterial infections in periodontal defects. Controlled local
delivery of antimicrobials into the defect sites presents many
advantages compared to oral administration, including site-
specific delivery, decrease of dose requirement and of side effects
in the body [9,10]. GTR membranes loaded with antibiotics for
local drug release have been reported [11], but many challenges
regarding to the correct design of drug release systems still exist.
Biocompatible and biodegradable micro/nanofibers produced
by electrospinning, which display high surface area-to-volume
ratio, porous structure, mechanical performance, and resemblance
to the extracellular matrix, have appeared as potential candidates
for GTR using synthetic and natural polymers as well as polymer
blends [3,12–16]. In coaxial electrospinning two different solutions
are spun simultaneously through two concentrically aligned capil-
laries to generate core-sheath structured nanofibers or other types
of structures, such as hollow nanofibers [17]. Coaxial electrospin-
ning enables the preparation of nanofibers from different type of
materials and even from unspinnable liquids, as they can be sup-
plied as the inner or outer fluid to produce nanofibers under the
guidance, respectively, of the spinnable outer or inner fluid. This
strategy allows the production of core–sheath nanofibers as well
as monolithic nanofibers that cannot be produced by a single-
fluid process [17–21]. In this regard, coaxial electrospinning has
been widely applied to prepare drug delivery systems in which
the release of incorporated drug can be modulated by varying
the structure and composition of the nanofibers [17–24].
Among different biocompatible and biodegradable polymers
that can be used to produce coaxial nanofibers, chitosan is of out-
most importance once it is atoxic, and exhibits antimicrobial and
hemostatic activities [25,26]. These properties make chitosan one
of the most widely studied natural biopolymers for a great variety
of biomedical applications including drug delivery systems [27],
wound dressings [28,29] and tissue engineering [30]. Chitosan, a
b(1? 4)-linked copolymer of 2-amino-2-deoxy-D-glucopyranose
(GlcN) and 2-acetamido-2-deoxy-D-glucopyranose (GlcNAc), is
generally prepared by carrying out the N-deacetylation of chitin,
a polysaccharide abundantly present in the exoskeletons of crus-
taceans, mollusks and insects [31,32]. The physicochemical proper-
ties, the in vivo degradation, biological activity and processability
of chitosan, are mainly affected by its molecular weight and aver-
age degree of deacetylation (DD), which expresses the number of
GlcN units along the chains [33]. Therefore, the properties of
chitosan-based biomaterials are strongly dependent on the struc-
tural characteristics of this biopolymer.
Despite the potential of chitosan for designing electrospun-
based biomaterials, its electrospinnability is largely limited mainly
due to repulsive forces between protonated ANH2 groups pertain-
ing to GlcN units (once the aqueous dilute acid used to dissolve the
polymer results in the protonation of such groups). To overcome
such a severe limitation, the blend of chitosan with nonionicPlease cite this article as: D. M. dos Santos, P. A. M. Chagas, I. S. Leite et al., C
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(PCL), has been proposed to render the chitosan solution more
electrospinnable [34,35]. Additionally, chitosan-based structures
generally possess weak mechanical properties and low stability
in aqueous medium, which limits its biomedical applications.
Chemical and/or physical crosslinking of chitosan is one of the
approaches employed to improve the stability of these structures
[36,37]. Genipin, a natural crosslinking compound isolated from
fruits of Gardenia jasminoides Ellis (gardenia) or unripe fruits of
Genipa americana L. (genipap), has been used to produce self-
sustainable, biocompatible, noncytotoxic chitosan-based materials
[38–40].
In this context, this study focuses on the development of a drug
delivery system based on coaxial electrospun nanofibers intended
to be applied as GTR membrane for periodontal regeneration.
Tetracycline hydrochloride (TH), a broad-spectrum antibiotic that
presents activity against both Gram-positive and Gram-negative
bacteria, was chosen as model drug. Two samples of chitosan pos-
sessing different average degree of deacetylation (DD) and similar
viscosity average molecular weight (Mv) were synthesized and
coaxially electrospun as shell component (outer layer) while poly
(vinyl alcohol) (PVA) loaded with TH was used as the core material
(inner layer). PVA was chosen because it is a biocompatible,
biodegradable and easily electrospinnable polymer [41,42]. The
effects of average degree of deacetylation and post-
electrospinning genipin crosslinking on the fibers’ structural and
physical properties were investigated. The nonwovens were char-
acterized with respect to morphology, surface and mechanical
properties, water absorption capacity and biological properties,
including cytocompatibility, biodegradability and antibacterial
properties, as well as release profile of TH. To the best of our
knowledge, there has been no report on the coaxial electrospinning
of chitosan possessing different structural characteristics and the
evaluation of post-electrospinning genipin crosslinking on the
physicochemical, biological and drug release profile.2. Materials and methods
2.1. Materials
Poly (vinyl alcohol) (PVA), with Mw = 31.000–50.000 g mol1,
tetracycline hydrochloride (TH), and lysozyme human
(100.000 units/mg) were acquired from Sigma-Aldrich (Saint Louis,
MO; USA), while genipin was purchased from Challenge Bioprod-
ucts Co. Ltd. (Taiwan, China). Acetic acid (99.8%) was acquired from
Synth (Diadema/SP; Brazil). The reactants and solvents employed
in this study were used as received.
2.2. Chitosan preparation
Initially, b-Chitin was extracted from squid pens (Doryteuthis
spp.) by treating the biomass with 1 M aqueous NaOH at room
temperature for 18 h as proposed by Chaussard and Domard [43],
which was then submitted to cryo-grinding and sieving. Chitosan
was prepared by applying the ultrasound-assisted deacetylation
(USAD) process to b-chitin particles (0.125 mm < d < 0.250 mm)
as described by Fiamingo and Campana-Filho [44]. Briefly, 5 g of
b-chitin was suspended in 50 mL of aqueous NaOH (40% w/w)
and the suspension was poured into a cylindrical double-walled
glass reactor (hint = 3.5 cm) coupled to a circulating thermostat.
Following, the suspension was submitted to ultrasound irradiation
for 50 min at 60 ± 0.5 C using the UP400S Hielscher Sonifier ultra-
sonic device (m = 24 kHz) coupled to a 22 mm stepped probe, with
pulsed irradiation (0.5) and ultrasound power set to 200W. Afterore-sheath nanostructured chitosan-based nonwovens as a potential drug
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ized with concentrated hydrochloric acid, filtered and the resulting
chitosan was thoroughly washed with water and freeze-dried. This
procedure resulted in low deacetylated chitosan (C1), which was
submitted to a further USAD processing to result in highly deacety-
lated chitosan (C2). It is important to highlight that as the multi-
step USAD process is carried out at relatively low temperature
(compared to conventional chemothermal deacetylation of chitin),
the USAD chitosans present high molecular weight, well-defined
average degree of acetylation and predominant block-wise distri-
bution of GlcN and GlcNAc units.
Owing to the high molecular weight of the USAD chitosans,
their solutions presented very high viscosity, precluding its use
in the electrospinning experiments. Thus, both USAD chitosans
C1 and C2 were submitted to depolymerization via ultrasound
treatment as reported in the literature [33], and the so-treated
samples presenting lower molecular weight were named as chi-
tosans CL and CH, respectively. The chitosans were characterized
and then used in electrospinning experiments. Thus, the average
degree of deacetylation (DD) of C1 and CL was 82%, while for C2
and CH chitosans was 93%, as determined by 1H NMR analysis
[45]. The viscosity average molecular weight (Mv) of the chitosans
C1, C2, CL and CH was determined from the corresponding intrinsic
viscosity measurements in 0.3 mol L1 acetic acid/0.2 mol L1
sodium acetate buffer (pH 4.5) at 25.00 ± 0.01 C using the Mark–
Houwink–Sakurada equation and taking into account their average
degree of acetylation [46]. These experiments revealed that C1 and
C2 chitosans presented Mv = 325.000 ± 22.000 g mol1 and
Mv = 290.000 ± 18.000 g mol1, respectively, while the depolymer-
ized USAD chitosans CL and CH presented
Mv = 111.000 ± 6.000 g mol1 and Mv = 104.000 ± 5.000 g mol1,
respectively.
2.3. Electrospinning process
Chitosan was dissolved in 50 wt% aqueous acetic acid upon stir-
ring for 18 h at room temperature to result in a transparent solu-
tion displaying Cp = 40 mg mL1, which was used to compose the
nanofiber shell upon coaxial electrospinning. A PVA solution
(Cp = 120 mg mL1) was prepared in 50 wt% aqueous acetic acid
upon stirring for 2 h at 90 C, which was used after cooling to room
temperature to compose the nanofiber core. PVA/ tetracycline
hydrochloride (TH) solution was prepared by dissolving TH at a
concentration of 10 mg mL1 in the previously prepared PVA solu-
tion under constant stirring for 20 min. Prior to electrospinning,
the solution conductivities were determined using a conductivity
meter (Gehaka, model CG 1800) at 25.0 ± 0.2 C while the dynamic
viscosity (m, cP) was calculated from the solution flow time (at
25.0 ± 0.2 C) using a falling-ball viscometer (GILMONT instru-
ments)according to Eq. (1).
l ¼ K qball  qsolutionð Þt ð1Þ
where qball = density of tantalum ball (16.6 g cm
3); qsolution = den-
sity of spinning solution (g cm3); t = time of descent of ball
(min.); K = viscometer constant (37).
The electrospinning process was carried out in a homemade
apparatus composed of a high voltage power supply (Glassman
High Voltage, Inc., USA), two syringe pumps (New Era Pump Sys-
tems, Inc., USA) to control the flow rates of core and sheath fluids,
and a metallic drum collector to collect the nanofibers. For coaxial
electrospinning, the solutions of chitosan and PVA/TH (or PVA
solution) were transferred into 3 mL syringes, and pumped sepa-
rately through the concentrically aligned outer and inner needle,
respectively. Diameters of the outer and the inner needle were
1.02 mm and 0.65 mm, respectively. The flow rate of the shell solu-Please cite this article as: D. M. dos Santos, P. A. M. Chagas, I. S. Leite et al., Co
delivery system for periodontitis treatment, International Journal of Biologicaltion was set at 10 mL min1, while that of the inner fluid was
5 mL min1. A working distance of 5 cm was kept between the nee-
dle and the collector and a voltage of 25 kV was applied. Fibers
were directly electrospun onto the stainless-steel drum collector
(L = 15.0 cm, W = 7.3 cm, rotation at 180 rpm) covered with an
aluminum foil. All experiments were carried out during 2 h
40 min. at 25 ± 3 C and a relative humidity of 25–40%. After elec-
trospinning, the resulting nonwovens were carefully removed from
the aluminum foil, dried at 30 C for 12 h and stored in a desiccator
before further use. The resulting nonwovens containing tetracy-
cline were named as CL/PVA-TH and CH/PVA-TH, while those with-
out antibiotic were named as CL/PVA and CH/PVA, respectively.
2.4. Crosslinking treatment using genipin
Core-sheath electrospun nanofibrous nonwovens were cross-
linked upon immersion in genipin ethanolic solution (5 mg mL1)
at room temperature for 15 min. Next, an excess of absolute etha-
nol was used to wash away the samples after the crosslinking reac-
tion. Then, the cross-linked nonwovens were dried at 30 C for 12 h
and stored in a desiccator. The genipin cross-linked nonwovens
were named as G(CL/PVA), G(CH/PVA), G(CL/PVA-TH) and G(CH/
PVA-TH).
2.5. Characterization
2.5.1. Morphology of nanofibers
The fibers’ morphology was investigated with a scanning elec-
tron microscope (SEM, JEOL 6510) using an acceleration voltage
of 10 kV after sputter coating the samples with gold. The fibers’
average diameter was determined from the SEM images using Ima-
geJ 1.45 software (National Institutes of Health, Bethesda, MD,
USA), measuring at least 150 random fibers from 6 micrographs
of each nonwoven. The Core-sheath structure of the fibers was
characterized by transmission electron microscopy (TEM, JEOL
JEM2100 LaB6) with an acceleration voltage of 200 kV. To prepare
the samples for TEM analysis, the fibers were deposited directly
onto 300-mesh carbon-coated Cu grids.
2.5.2. Attenuated total reflectance Fourier transform infrared
spectroscopy
ATR-FTIR spectra of electrospun nonwovens were recorded on a
Bruker vertex 70 spectrometer using a universal attenuated total
reflection (ATR) accessory. Spectra were recorded between 4000
and 600 cm1 by the accumulation of 32 scans and a resolution
of 4 cm1.
2.5.3. Contact angle, surface and interfacial free energy
Contact angle (CA) measurements were carried out using a
goniometer (CAM 2008, KSV) equipped with CAM 2008 software.
Nonwovens samples (15 mm  10 mm) were attached to glass
slides and apparent contact angles were determined from the ses-
sile profile droplets (approx. 3 lL) of three liquids of different
polarities (deionized water, diiodomethane and ethylene glycol)
1 s after deposition. Each sample was evaluated at five different
points at room temperature. Contact angle data and the surface
tension components of the probe liquids (cL, cLWL , cL , c
þ
L ) [47] were
used to calculate the nonwovens surface free energy and surface
energy components using the van Oss, Chaudhery and Good model
[48] as described by [49]. Briefly, the total surface energy (cTOTAL)
was calculated by the sum of the apolar (cLW) and polar (cAB) com-
ponents (cTOTAL = cLW + cAB), the latter being calculated from elec-
tron acceptor component (c+) and electron donor component (c─).
The hydrophobicity (hydrophilicity) of surface nonwovens was
quantitatively assessed from the interfacial free energy (DG),re-sheath nanostructured chitosan-based nonwovens as a potential drug
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vens (cLWS , cS , c
þ
S ) and surface tension parameters of deionized
water (cLWW , cW , c
þ
W ) [50].
2.5.4. Swelling capacity
The swelling behavior of the nonwovens was assessed using a
gravimetric method proposed by Dos Santos et al. (2018) with
modifications. Nonwovens were cut into strips (2 cm  2 cm),
weighted and then immersed in 25 mL of phosphate-buffered sal-
ine (PBS), pH 7.4 at 37 C in an incubator. At predetermined time
up to 30 min., the samples were taken out of the fluid, blot dried
and weighed. The swelling ratio was calculated according to Eq.
(2). Five repeats of each nonwoven composition were evaluated.
Swelling Ratio %ð Þ ¼ ððWwet WdryÞ=WdryÞ  100 ð2Þ
whereWdry andWwet correspond to the weight of dried and swollen
mats, respectively.
2.5.5. In vitro enzymatic degradation
The in vitro biodegradability of nonwovens was studied by incu-
bating them at 37 C for 14 days in phosphate-buffered saline (PBS,
pH = 7.4) containing lysozyme (276 mg L1). Nonwovens strips
(2 cm  2 cm) were weighed and placed into individual vials
(20 mL) containing 5 mL of buffer solution. At predetermined times
(6 h, 12 h, 1, 2, 4, 7 and 14 days), samples were removed from the
buffer, washed with deionized water, freeze-dried at 55 C for
48 h, and weighed. The mass percent remaining of the nonwoven
was calculated according to Eq. (3). Control tests, which corre-
spond to incubation in the absence of lysozyme, were also carried
out. All experiments were carried out in triplicate.
Mass remaining %ð Þ ¼ ðWt=W0Þ  100 ð3Þ
where W0 is the initial weight of the nonwoven and Wt is its weight
after degradation.
2.5.6. Tensile properties
Tensile tests of rectangular specimens of nonwovens
(20 mm  6.4 mm) were carried out using a Q800 from TA Instru-
ments in tension mode using a thin film clamp at 25 C. The dis-
tance between grips was kept at 5 mm, and the tests were
carried out with ramp strength of 1 N/min up to 18 N. At least five
samples were evaluated for each specimen and the tensile strength
(MPa), elastic modulus (MPa) and elongation-at-break (%) were
determined from stress-strain curves.
2.5.7. In vitro drug release study
In vitro release of tetracycline hydrochloride (TH) was evaluated
by immersing 10 mg of nonwovens in 7 mL phosphate-buffered
saline (PBS, pH = 7.4) containing lysozyme (276 mg L1) at 37 C
under shaking at 60 rpm in an incubator. At predetermined time
intervals, an aliquot of the medium (0.7 mL) was withdrawn and
replaced by fresh solution. The amount of TH released in the incu-
bation medium was quantified using UV spectrophotometry (Shi-
madzu, UV-1800) at 360 nm based on a previously prepared
calibration curve. Control tests, which correspond to incubation
in the absence of lysozyme, were also carried out. Each experiment
was performed in triplicate and the results were expressed in
terms of cumulative release as a function of release time.
2.5.8. Cell viability study
Neonatal human dermal fibroblast cell line (HDFn, Gibco, cat.
nC0045C) was acquired from Thermo Fischer Scientific (Waltham,
MA, USA). The cells were tested between passages 15 and 20 and
were grown continuously in humidified incubator (MCO-17AC,
Sanyo Electric Co. Ltd., Osaka, Japan) at 37 C and 5% CO2 atmo-Please cite this article as: D. M. dos Santos, P. A. M. Chagas, I. S. Leite et al., C
delivery system for periodontitis treatment, International Journal of Biologicalsphere with Dulbecco’s Modified Eagle Medium (DMEM) supple-
mented with 10% (v/v) fetal bovine serum (FBS) and 0.5% (v/v)
penicillin-streptomycin, all purchased from Cultilab (Campinas,
SP, Brazil). Cell viability experiments were carried out according
to the protocol adapted from ISO 10993-5 [51] and described by
Neamnark et al. [52]. In brief, cross-linked nonwovens strips
(20 mm  20 mm) were sterilized with ethanol and extracts were
prepared through 24 h of incubation with fresh phenol-red free
DMEM supplemented with 10% FBS at 37 C and 5% CO2 atmo-
sphere (extraction ratio: 4 mg mL1). Simultaneously, 96 well-
plates were seeded with 5  104 cells mL1 in DMEM supple-
mented with 10% FBS and incubated in humidified incubator at
37 C and 5% of CO2 for 24 h. Cell medium was then replaced by
100 mL of pure (4 mg/mL) or serial diluted nonwovens extracts (4,
2, 1, 0.5 and 0.1 mg mL1) or phenol-red free DMEM with 10%
FBS (control group) and the plates were incubated for 24 h in
humidified incubator. Cell viability was assessed indirectly by the
MTT assay (stock solution: 5 mg mL1). Absorbance values were
measured with the microplate spectrophotometer MultiskanTM
GO (Thermo Fischer Scientific) at 570 nm, and viability values were
calculated considering the absorbance values of the control group
(i.e., cells cultured in medium without nonwovens extracts) as
100% of viability. Experiments were conducted in triplicates of
each group and repeated in three different occasions (total n = 9).2.5.9. Antibacterial activity experiments
2.5.9.1. Activity test against periodontal pathogens. The antibacterial
activities of the nanofibrous nonwovens against a series of bacte-
rial strains associated with periodontal disease obtained from
human periodontal subgingival pocket of patients with chronic
periodontitis were evaluated according to the protocol established
by Clinical and Laboratory Standards Institute (CLSI) [53] Initially,
clinical samples were collected from human periodontal subgingi-
val pocket of three patients presenting at least 10 periodontal sites
with bleeding and probing depth 5 mm. Patients spontaneously
adhered to this study and to select them, the following criteria
were adopted: absence of positive history of antibiotic use or any
type of periodontal treatment at least 3 months prior to this study
as well as immunosuppressive diseases or systemic changes evi-
dent on clinical examination or detected by anamnesis. The Ethics
and Research Committee of the Sao Paulo State University (UNESP)
approved the collection of plaque samples and all patients signed
free informed consent in accordance with Resolution No. 196/96
of the Directives and Norms of the National Health Council.
Subgingival plaques were collected from the premolars and
molars using Gracey’s curettes and suspended in sterile saline
solution. After this treatment, the resulting suspension was cen-
trifuged and a portion of plaque pellet was resuspended in
150 lL of Tris-EDTA buffer solution (10 mM Tris, 1 mM EDTA)
(pH 7.6) and 100 lL of 0.5 mol L1 NaOH, and then submitted to
checkerboard DNA-DNA hybridization analysis according to the
methodology proposed by Socransky et al. [54] in order to identify
the bacterial strains present in periodontal plaques. Nonwovens
disks (/ = 10 mm, n = 3/group) were used in order to assess the
growth inhibition toward bacterial strains associated to periodon-
titis. For these experiments, subgingival plaques pellets previously
prepared were resuspended in brain-heart infusion broth and sus-
pension concentration was adjusted to 1  108 cell mL1. Then,
the surface of a supplemented sheep blood agar plate was uni-
formly seeded with a sterile cotton swab containing the microor-
ganisms and samples of each nonwovens were placed on the
agar plate, which was incubated under anaerobic condition (80%
N2  10% CO2  10% H2) at 37 C for 4 days. After incubation, each
plate was examined to evaluate the growth inhibition of microor-
ganisms in regions around the nonwovens, according to the pres-ore-sheath nanostructured chitosan-based nonwovens as a potential drug
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with absence of growth detectable by the naked eye.2.6. Statistical analysis
All data were expressed as the mean ± standard deviation. In
order to check for any statistically significant differences, an one-
way analysis of variance (ANOVA) was performed followed by
Tukey’s post hoc test at the 95% confidence level using an open-
source statistical programming language R v. 3.1.1.3. Results and discussion
3.1. Conductivity and viscosity of spinning solutions
Coaxial electrospinning technique was employed to prepare
chitosan-based core-sheath nanofibers aiming to develop a novel
drug delivery platform for periodontitis treatment. Two different
chitosans possessing well-defined characteristics in terms of aver-
age degree of deacetylation (DD) and viscosity average molecular
weight (Mv) were used to prepare the solutions employed for elec-
trospinning the shell of the nanofibers while solutions of PVA or
PVA/TH were coaxially electrospun to produce the core layer. The
optimized electrospinning parameters were defined by subsidiary
experiments (results not shown), where parameter effects such
as electric field strength, polymer concentration and flow rate were
investigated. Based on these experiments, the applied voltage and
spinneret-to-collector distance were fixed at 25 kV and 5 cm,
respectively, while the flow rate of the shell and core solutions
were set at 10 mL min1 and 5 mL min1, respectively, which
allowed the production of nonwovens composed by nanofibers dis-
playing the aimed core-sheath structure.
The physicochemical properties of polymer solution, mainly its
conductivity, and viscosity, play a crucial role in the electrospin-
ning process. In this sense, the conductivity and viscosity of spin-
ning solutions were measured as shown in Fig. 1. As expected,
the conductivity of PVA solution increased by addition of TH due
to its ionic character, while solution viscosity was not affected by0
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tivity increases with increasing the average degree of acetylation of
chitosan, which is attributed to the higher content of protonated
amino groups of 2-amino-2-deoxy-D-glupyranose units pertaining
to the parent chitosan [49,55]. The solution viscosity of shell solu-
tions was not affected by their composition and this behavior can
be explained by the similar values of viscosity average molecular
weight (Mv) of parent chitosans.
3.2. Morphology and core-sheath structure of nanofibers
The surface morphology of nonwovens was analyzed by scan-
ning electron microscopy (SEM), which representative micro-
graphs are displayed in Fig. 2. The morphological analysis
revealed the non-cross-linked nonwovens as densely packed
network-like structures composed by smooth bead-free nanofi-
bers. The corresponding fiber diameter histograms show that the
fibers’ diameter is predominantly in the range 100250 nm, except
in the case of nonwoven CH/PVA sample, whose fiber diameter
range is wider (150–350 nm). The morphology and diameter of
electrospun fibers are strongly affected by the conductivity and
viscosity of spinning solutions and an adequate combination of
both parameters is fundamental to yield defect-free, beadless,
and geometrically uniform fibers [56]. In this sense, the changes
in fiber morphology and size distribution observed for CH/PVA
nonwoven can be attributed to the low conductivity of PVA solu-
tion, which leads to the ejection of thicker jets, and to the high con-
ductivity and viscosity of spinning solution prepared from highly
deacetylated chitosan (CH), which increases the instability of the
ejected jets, thus increasing the broadness of fiber diameter
distribution.
After crosslinking with genipin, the homogeneous fibrous struc-
ture of nonwovens was retained, but a slight change in fiber mor-
phology and diameter distribution was observed in all cases as a
consequence of the crosslinking (Fig. 2a). Such behavior was more
pronounced in the case of nonwoven G(CH/PVA-TH), whose aver-
age fiber diameter was higher (234 ± 54 nm) as compared to that
of CH/PVA-TH nonwoven (174 ± 33 nm), and a broader fiber diam-
eter distribution was observed. The slight change in fiber diameterPVA
PVA
+TH CL CH
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Fig. 2. SEM micrographs of non-cross-linked nonwovens (CL/PVA (a), CL/PVA-TH (c), CH/PVA (e), CH/PVA-TH (g)) and cross-linked nonwovens (G(CL/PVA) (b), G(CL/PVA-TH)
(d), G(CH/PVA) (f), G(CH/PVA-TH) (h)), as well as the corresponding histograms showing fiber diameter distributions.
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nonwoven due to their porous structure, causing swelling of fibers.
The morphological differences observed between G(CH/PVA-TH)
and G(CL/PVA-TH) can be explained by the structural characteris-
tics of parent chitosan. Indeed, since CL is less deacetylated
(DD = 82%) than CH (DD = 93%), the crosslinking process is favored
for the latter due to the higher content of amino groups of 2-
amino-2-deoxy-D-glupyranose units. In such case, there is a reduc-
tion of the interpenetration between genipin cross-linked chitosan
and PVA-TH layers, thus favoring the expansion of PVA-TH net-
work due to its higher affinity to ethanol, which results in an
increase of G(CH/PVA-TH) fiber diameter.
Transmission electron microscopy (TEM) was used to confirm
the Core-sheath structure of nanofibers. TEM micrographs (Fig. 3)
of cross-linked and non-cross-linked fibers exhibit a clear bilayer
structure with the inner layer showing a dark gray color and the
outer layer showing a light gray color, thus indicating that the
coaxial electrospinning was successful and that the integrity of
core-sheath structure of fibers was kept after crosslinking with
genipin.3.3. ATR-FTIR analysis
The ATR-FTIR spectra of less deacetylated chitosan (CL), PVA
and TH in powder form as well as those of the nonwovens CL/Please cite this article as: D. M. dos Santos, P. A. M. Chagas, I. S. Leite et al., C
delivery system for periodontitis treatment, International Journal of BiologicalPVA-TH and G(CL/PVA-TH) are compared in Fig. 4a to give insight
on the characteristics functional groups of nonwovens. The spec-
trum of chitosan exhibits an absorption band centered at
1658 cm1 related to the C@O stretching of amide I and a band
at 1590 cm1 that corresponds to NAH bending of primary amine
[57,58]. The spectrum of PVA shows a typical band at 1423 cm1
related to the bending of the CAH bond of methylene groups
[59]. The spectrum of TH exhibits characteristic absorption bands
at 1676, 1613, 1577, 1530 and 1448 cm1 due to the C@O vibration
of Amide I, C@O vibration of aromatic ring, C@O vibration of C-ring,
NH2 deformation of Amide II and C@C vibration of aromatic ring,
respectively [60]. Accordingly, the spectra of CL/PVA-TH and G
(CL/PVA-TH) nonwovens show absorption bands at 1658 cm1
and 1590 cm1, characteristic of chitosan, and a band at
1423 cm1 related to the presence of PVA. However, the low con-
tent of TH impairs the clear identification of its characteristics
bands on G(CL/PVA-TH) nonwoven spectrum. In addition, the
bands corresponding to the primary amine (at 1590 cm1) and to
amide I (at 1658 cm1) are less and more intense, respectively, in
the spectrum of G(CL/PVA-TH) nonwoven (Fig. 4b). Such facts indi-
cate that some primary amine groups of GlcN units of chitosan
have been consumed by the reaction with genipin to result in
crosslinking and to form secondary amine groups. Indeed, taking
into account the conditions used in this study to carry out the
crosslinking reaction, its mechanism involves the nucleophilicore-sheath nanostructured chitosan-based nonwovens as a potential drug
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Fig. 3. TEM micrographs of core-sheath non-cross-linked nanofibers (CL/PVA (a), CL/PVA-TH (c), CH/PVA (e), CH/PVA-TH (g)) and cross-linked (G(CL/PVA) (b), G(CL/PVA-TH)
(d), G(CH/PVA) (f), G(CH/PVA-TH) (h)) nanofibers.
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Fig. 4. ATR-FTIR spectra of TH, PVA and chitosan CL in the powder form and of CL/PVA-TH and G(CL/PVA-TH) nonwovens (a); ATR-FTIR spectra magnification in the range
1800–1500 cm1 showing the comparison between cross-linked and non-cross-linked nonwovens (b).
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olefinic carbon atom at C-3 of genipin and the subsequent opening
of the dihydropyran ring followed by a nucleophilic attack of the
secondary amino group to the newly formed aldehyde group,
resulting in a cross-linked polymer network [61]. It is important
to highlight that comparing the spectra of the other cross-linked
and non-cross-linked nonwovens revealed the same trend as thatPlease cite this article as: D. M. dos Santos, P. A. M. Chagas, I. S. Leite et al., Co
delivery system for periodontitis treatment, International Journal of Biologicalobserved in the comparison of nonwovens CL/PVA-TH and G(CL/
PVA-TH).
3.4. Surface free energy and hydrophilicity of nonwovens
The nonwoven surface free energy and surface energy compo-
nents (Table 1) were determined from contact angle (CA) measure-re-sheath nanostructured chitosan-based nonwovens as a potential drug
Macromolecules, https://doi.org/10.1016/j.ijbiomac.2019.09.124
Table 1
Surface energy components* and interfacial free energy of interaction (DG) of nonwovens (in mJ m2).
Sample** cLW c+ c- cAB cTOTAL DG
CL/PVA 36.7 ± 0.2a 0.17 ± 0.01a 72.2 ± 0.9 a 7.1 ± 0.3a 43.8 ± 0.5a 60.1 ± 0.6a
G(CL/PVA) 39.7 ± 0.6b 0.04 ± 0.01b 31.3 ± 0.7b 2.5 ± 0.1b 42.0 ± 0.9a 5.2 ± 0.8b
CL/PVA-TH 34.2 ± 0.1c 0.14 ± 0.01c 70.4 ± 0.9 a 6.3 ± 0.2c 40.5 ± 0.1b 59.7 ± 0.9a
G(CL/PVA-TH) 41.0 ± 0.8d 0.13 ± 0.03c 38.9 ± 0.9c 4.5 ± 0.6d 44.1 ± 3.2a 16.6 ± 0.4c
CH/PVA 36.1 ± 0.8a 0.05 ± 0.02b 68.4 ± 0.3d 4.3 ± 0.3d 39.2 ± 1.6b 59.1 ± 1.0 a
G(CH/PVA) 41.0 ± 0.1d 0.05 ± 0.01b 30.5 ± 0.3b 2.3 ± 0.3b,f 43.3 ± 0.4a 3.4 ± 0.1d
CH/PVA-TH 38.4 ± 0.3e 0.21 ± 0.01d 71.3 ± 4.4a 7.9 ± 0.1e 46.5 ± 0.1c 60.3 ± 0.4a
G(CH/PVA-TH) 39.4 ± 0.4b 0.04 ± 0.004b 31.6 ± 2.5b 2.2 ± 0.1f 40.9 ± 0.9a 3.5 ± 0.9d
* Dispersive (cLW), electron-donor (c), electron-acceptor (c+), acid-base (cAB); total surface energy (cTOTAL).
** Means followed by the same letter in the columns do not differ by a Tukey’s test at the 95% confidence level.
 CL/PVA 
 G(CL/PVA)
 CH/PVA 
 G(CH/PVA)
0 5 10 15 20 25 30
0
50
100
150
200
250
300
350
 CL/PVA-TH
 G(CL/PVA-TH)
 CH/PVA-TH
 G(CH/PVA-TH)
Sw
el
lin
g 
(%
)
Time (min.)
Fig. 5. Swelling behavior of non-cross-linked (CL/PVA, CL/PVA-TH, CH/PVA, CH/
PVA-TH) and cross-linked (G(CL/PVA), G(CL/PVA-TH), G(CH/PVA), G(CH/PVA-TH)
nonwovens in phosphate-buffered saline (PBS), pH 7.4 at 37 C.
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different polarities, namely water, ethylene glycol and diiodo-
methane, and by using the method proposed by Good, van Oss
and Chaudhery [48].
Surface free energy components of nonwovens are related to
many interfacial processes such as absorption and wetting of aque-
ous fluids, thus influencing their applications in biomedical field.
As can be seen in Table 1, for all nonwovens the contribution of
the dispersive component (cLW), which accounts the capacity of
the surface to take part in London or dispersive interactions, to
the total surface energy (cTOTAL) is higher than the contribution
of the polar component (cAB), which is associated to all the other
possibilities of interactions (induction, dipole, and hydrogen bond-
ing). Results also reveal that the polar component contribution to
total surface energy decreased upon crosslinking the nonwovens.
A similar trend was also observed concerning the electron-donor
component (c─) of the polar component. Additionally, the
electron-donor component of the polar surface energy dominated
over the electron-acceptor (c+) one (c/c+ 1), thus indicating
that the surface of the nonwovens possesses strong electron donat-
ing capacity and ability to participate in polar interactions with
acid species [47,50].
The interfacial free energy (DG) of the nonwovens was calcu-
lated in order to evaluate the hydrophilic or hydrophobic nature
of theirs surfaces. By thermodynamic convention, when DG > 0
the interaction of the material surface with water dominates and
the surface of the material is hydrophilic, while DG < 0 indicates
that the interaction of surface components (cohesive attraction)
of the material is favored rather than forming an interface withPlease cite this article as: D. M. dos Santos, P. A. M. Chagas, I. S. Leite et al., C
delivery system for periodontitis treatment, International Journal of Biologicalwater. Results expressed in Table 1 demonstrate that DG > 0 for
all nonwovens and that the increase of average degree of deacety-
lation for chitosan did not affect DG values. However, genipin
crosslinking resulted in reduction of interfacial free energy values,
which indicates that less hydrophilic groups are exposed at the
surface of the cross-linked nonwovens. This behavior corroborates
the results from ATR-FTIR spectroscopy, which evidenced the band
intensity decrease due to amino groups of GlcN units because of
genipin crosslinking. Taking into account the whole set of results,
the decrease of hydrofilicity may be considered a desirable attri-
bute for enhancing the stability of these materials in aqueous med-
ium and to control the release of hydrophilic drugs incorporated
inside the core layer of nanofibers.
3.5. Swelling behavior
A GTR membrane should have adequate fluid absorption capac-
ity regarding its exposition to blood and body fluids during its
application. In this regard, the swelling capacity of nonwovens
was investigated by immersing them into PBS at 37 C, and the
results are summarized in Fig. 5. As can be seen, all nonwovens
were able to quickly absorb PBS as the swelling equilibrium condi-
tion was reached in 1 min. and 5 min. in the cases of non-cross-
linked and cross-linked nonwovens, respectively. Results also
reveal that the maximum swelling capacity decreased upon
crosslinking, which is attributed to the decrease of the hydrophilic
character of nonwovens. In addition, CH/PVA and CH/PVA-TH non-
wovens exhibited, respectively, the highest and lowest maximum
swelling capacity among the non-cross-linked nonwovens, while
no significant difference was observed when comparing CL/PVA
and CL/PVA-TH nonwovens. After crosslinking, the maximum
swelling capacity values were not significantly affected by struc-
tural characteristics of chitosan and by the presence of antibiotic.
Overall, the decrease of swelling capacity upon crosslinking is
advantageous, since high swelling ratios are not favorable because
the space occupied in site defect by the GTR membranes is limited
and higher fluid absorption may lead to higher infiltration of
fibroblast cells, thus hindering an adequate periodontal regenera-
tion [11].
3.6. In vitro biodegradability
Determination of the in vitro degradability of the nonwovens
allows the prediction of their stability in aqueous medium, which
is suitable to avoid their removal by an additional surgical proce-
dure and to provide space for newly formed tissues [7,11]. Aiming
to simulate real conditions of application, the in vitro biodegrad-
ability of nonwovens was evaluated in a phosphate buffer solution
(pH 7.4) at 37 C for 14 days in the absence and presence of lyso-
zyme (276 mg/L) as presented in Fig. 6a and 6b, respectively. The
lysozyme concentration used in this study corresponds to that
found in gingival crevicular fluid [62–64]. Lysozyme is an impor-ore-sheath nanostructured chitosan-based nonwovens as a potential drug
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Fig. 6. In vitro degradation profiles of non-cross-linked (CL/PVA, CL/PVA-TH, CH/PVA, CH/PVA-TH) and cross-linked (G(CL/PVA), G(CL/PVA-TH), G(CH/PVA), G(CH/PVA-TH)
nonwovens in the absence (a) and presence (b) of lysozyme in a phosphate buffer solution (pH 7.4) at 37 C; Cumulative release profile of tetracycline hydrochloride from
non-cross-linked (CL/PVA, CL/PVA-TH, CH/PVA, CH/PVA-TH) (c) and cross-linked (G(CL/PVA), G(CL/PVA-TH), G(CH/PVA), G(CH/PVA-TH) (d) nonwovens in the absence
(control) and presence of lysozyme.
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Gram-positive bacteria, and it is able to degrade chitosan-based
materials by hydrolyzing b (1? 4) glycosidic bond between GlcN
and GlcNAc units [25,64,65]. The in vitro degradation profiles of
nonwovens are presented in Fig. 6 and reveal that genipin
crosslinking expressively improves the stability of materials in
aqueous medium.
A substantial higher weight loss was observed in the cases of
non-cross-linked nonwovens after 1 day in the presence as well
as in the absence of lysozyme (remaining weight <45%) as com-
pared to cross-linked nonwovens, which remaining weight was
higher than 92% in both incubation media. In the absence of lyso-
zyme, the degradation profile of cross-linked nonwovens did not
differ significantly, regardless of acetylation average degree of chi-
tosan and presence of tetracycline hydrochloride, where the
remaining weight lied close to 85% after 14 days of incubation.
On the other hand, the structural characteristics of chitosan
strongly affect the weight loss profile of cross-linked nonwovens
in the presence of lysozyme as demonstrated by the increase of
stability of the nonwovens with increasing of the degree of
deacetylation. Thus, after 14 days of incubation the remaining
weights of nonwovens G(CL/PVA) and G(CL/PVA-TH) were both
quite low (65%) as compared to those of G(CH/PVA) and G(CH/
PVA-TH) nonwovens (85%). Such a behavior is explained by the
high content of sequences of diads GlcNAc/GlcNAc in the chainsPlease cite this article as: D. M. dos Santos, P. A. M. Chagas, I. S. Leite et al., Co
delivery system for periodontitis treatment, International Journal of Biologicalof chitosan CL (DD = 82%) as compared to CH (DD = 93%), which
favors the lysozyme activity [65,66]. Considering that GTR mem-
brane must be stable for at least 4–6 weeks to allow successful
regeneration of the periodontal system, it can be concluded that
nonwovens G(CH/PVA) and G(CH/PVA-TH) present higher poten-
tial to be used in periodontal regeneration [7,11].3.7. In vitro drug release
As demonstrated in Section 3.6, lysozyme is able to degrade
chitosan-based nonwovens, which may affect the release of tetra-
cycline hydrochloride (TH) from nonwovens. In this sense, the drug
release experiments were carried out in the presence as well as in
the absence of lysozyme. The cumulative percentage of TH released
from non-cross-linked (Fig. 6c) and cross-linked nonwovens
(Fig. 6d) reveals very different release behaviors. Indeed, regardless
of non-cross-linked nonwoven composition and incubation med-
ium, approximately 90% of TH was released within 60 min. Such
results indicate that the release of TH from non-crosslinked non-
wovens initially involves the swelling of polymer matrix, which
facilitates the solvent access to the drug incorporated in the poly-
meric matrix and the release of drug by diffusion mechanism. In
addition, the lack of stability of these materials in aqueous med-
ium, as evidenced by in vitro degradability study, also contributedre-sheath nanostructured chitosan-based nonwovens as a potential drug
Macromolecules, https://doi.org/10.1016/j.ijbiomac.2019.09.124
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delivery system for periodontitis treatment, International Journal of Biologicalto the faster release of TH associated to a dissolution mechanism
[67,68]. Similar results were reported by Qin et al. [69], which
incorporated aspirin into chitosan-based nanofibers prepared by
electrospinning demonstrating that the drug was completely
released after 60 s due to fast dissolution of polymeric matrix.
On the other hand, the cross-linked nonwovens exhibited a
small burst release of TH (15%) in the first 3 h followed by a sus-
tained release over a period of 14 days, in the presence and absence
of lysozyme (Fig. 6d). The initial burst release can be ascribed to
the dissolution of non-cross-linked portion of chitosan in the outer
shell and the PVA in the inner core. As previously demonstrated,
the crosslinking resulted in decrease of swelling capacity of non-
wovens as well as increase of the stability of these materials in
aqueous medium, thus decreasing the release rate of TH by diffu-
sion and dissolution of polymeric matrix and consequently pro-
moting a sustained release. This behavior can be also associated
to the core-sheath fibers structure, once the genipin-crosslinked-
chitosan in the sheath layer serves as a diffusive barrier for the
drug in the core layer. Several studies have demonstrated the
advantages of core-sheath nanofibers over monolithic nanofibers
for bioactive compounds release, including uniform distribution
of bioactive agent into the nanofibers, sustained release and pro-
tection of the incorporated bioactive compound [23,70–73]. For
example, Sultanova et al. [74] compared blended and coaxial elec-
trospun polycaprolactone (PCL)-based nanofibers for hydrophilicore-sheath nanostructured chitosan-based nonwovens as a potential drug
Macromolecules, https://doi.org/10.1016/j.ijbiomac.2019.09.124
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the drug release from the coaxial fibers exhibited better sustained-
release profiles with a smaller initial burst effect compared to drug
released from monolithic electrospun fibers.
Results also reveal that the release profile of TH from cross-
linked nonwovens in the presence of lysozyme was highly depen-
dent on the structural characteristics of chitosan, as a higher TH
release rate was observed from the nonwovens prepared from
the more acetylated chitosan (CL; DD = 82%). Indeed, these results
are in agreement with the findings from in vitro degradability
study of nonwovens, which evidenced the increase of stability in
aqueous medium in the presence of lysozyme when the more
acetylated chitosan (CL) was present in the shell layer. Overall, G
(CH/PVA-TH) nonwoven can be considered potentially useful as a
platform for local hydrophilic drug delivery in periodontitis treat-
ment, once it presented an initial burst release that can be advan-
tageous in improving the therapeutic effect at the beginning, and
the sustained release can hinder the occurrence of new bacterial
infection [11,75,76]. These novel sustained drug delivery systems
combine the benefits of core-sheath structure and the nontoxic
nature, biocompatibility, and biodegradability of chitosan in
sheath layer. In addition, it is well-known that chitosan exhibits
mucoadhesive property, which is desirable for designing drug
delivery systems by increasing the residence time and minimizing
the degradation of drug at the absorption site, thus improving the
therapeutic efficacy [77–79].3.8. Mechanical properties
A GTR membrane should have adequate mechanical properties
to facilitate handling and application and to support cells related to
periodontal regeneration [7]. In this regard, the mechanical proper-
ties of coaxial electrospun nonwovens were investigated by tensile
tests, and their typical strain-stress curves are presented in Fig. 7a,
while the elastic modulus, elongation at break and tensile strength
calculated from these curves are summarized in Fig. 7b, c and d,
respectively. As can be seen, after crosslinking the elastic modulusFig. 9. Bacterial strains present in samples extracted from human periodontal subgingiv
linked nonwovens without TH (G(CL/PVA), G(CH/PVA)) and containing TH (G(CL/PVA-
inoculated with periodontal pathogens.
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delivery system for periodontitis treatment, International Journal of Biologicaland tensile strength increased and the elongation at break
decreased, regardless of nonwoven composition. This behavior
may be explained by the formation of covalent bonds between
genipin and chitosan chains, which limits the mobility of the chain
segments and results in a more rigid material. It is worth noting
that all cross-linked nonwovens displayed tensile strength values
higher than 4 MPa and elongation at break lower than 7%, which
may be considered desirable attributes for reducing the risks of
material deformation and consequent infiltration of fibroblast cells
on periodontal defect, thus favoring the regeneration [7].3.9. Cytotoxicity assay
The previous discussions clearly demonstrate that genipin-
cross-linked nonwovens are potentially useful materials to be used
in periodontal regeneration. Regarding the potential biomedical
applications of these materials, their biocompatibility should be
evaluated. In this study, the cytotoxicity of the cross-linked non-
wovens toward neonatal human dermal fibroblast (HDFn) cells
was investigated using MTT assay. The fibroblast cells were cul-
tured in different concentrations of the extract solutions of the
nonwovens (4, 2, 1, 0.5 and 0.1 mg/mL), and the cytotoxicity was
estimated after 24 h (Fig. 8). Cell viability data reveal that regard-
less of extraction ratio, all nonwovens did not exhibit any toxicity
after 24 h in contact with the HDFn cells. In addition, no significant
difference in cell viability was noted between the different tested
nonwovens (p-value > 0.05). Although further in vitro and in vivo
investigations will be carried out in future experiments, the results
indicate that prepared nonwovens exhibited in vitro cytocompati-
bility and hence are prospective candidates for biomedical
applications.3.10. Assessment of antibacterial activity
In the present study, the antimicrobial activity of the cross-
linked nonwovens towards a series of bacterial strains obtained
from human periodontal subgingival pocket of patients withal pocket of patients with chronic periodontitis (a); Antibacterial results for cross-
TH), G(CH/PVA-TH)) (b), where the nonwovens were placed on plates previously
re-sheath nanostructured chitosan-based nonwovens as a potential drug
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highly complex bacterial microbiota, which colonization profile
varies qualitatively and quantitatively among individuals. Despite
the microbiological variation of each individual, associations
between 40 bacterial species present in the subgingival microbiota
of individuals with chronic periodontitis have been exhaustively
studied and classified by complexes: red, orange, yellow, green
and purple [80–82]. Yellow, purple and green complexes members
were recognized as early colonizers in periodontal diseases,
whereas orange complex precede the colonization of bacteria per-
taining to the red complex, which in turn are strongly related to
periodontal diseases [83–85].
Results in Fig. 9a reveal that clinical samples displayed a pre-
dominance of bacterial species of orange complex (Fusobacterium
nucleatum, Parvimonas micra, Prevotella nigrescens, Prevotella inter-
media, Eubacterium nodatum, Campylobacter gracilis, Campylobacter
rectus and Campylobacter showae) and red complex (Treponema
denticola, Tannerella forsythia and Porphyromonas gingivalis). A
homogeneous distribution of bacterial species of green, yellow,
purple complexes as well as other component species was also
identified.
Fig. 9b shows digital photo of the nonwovens on agar plates in
the presence of periodontal pathogens. As can be seen, cross-linked
nonwovens without TH incorporation (G(CL/PVA) and G(CH/PVA))
did not present bacterial inhibition zone formation against peri-
odontal pathogens owing to the lack of antibacterial properties of
these materials. In contrast, G(GL/PVA-TH) and G(CH/PVA-TH)
nonwovens inhibited the bacterial growth, as demonstrated by
bacterial inhibition zones for periodontal pathogens
(29.0 ± 1.0 mm and 29.0 ± 1.7 mm), thus indicating that the bacte-
rial inhibition effect is solely related to the incorporated antibiotic.
It is interesting to note that, although the G(CL/PVA-TH) and G(CH/
PVA-TH) nonwovens showed different drug release patterns, the
antimicrobial activity of them did not differ significantly (p-
value > 0.05) in the antibacterial tests. In addition, results also
reveal that the incorporation of TH inside the core of the nanofibers
does not compromise the inherent antibacterial activity of this
antibiotic. It is worth mentioning that G(GL/PVA-TH) and G(CH/
PVA-TH) nonwovens exhibited expressive activity towards a series
of bacteria including those of the red and orange complex, which
are recognized as pathogens in aggressive and chronic periodonti-
tis [83,86,87], therefore demonstrating their high potential to be
used in periodontal treatment.4. Conclusion
Nonwovens constituted by chitosan/poly (vinyl alcohol) elec-
trospun core-sheath nanofibers were successfully prepared via
coaxial electrospinning. The post-electrospinning genipin
crosslinking decreased the hydrophilicity, swelling ratio and
degradation rate of the nonwovens as well as improved their
mechanical properties. As a consequence of higher stability of
cross-linked nonwovens in aqueous medium, a sustained release
of TH from these structures was observed over 14 days. Moreover,
the degradation rate and the release profile of TH in simulated con-
ditions of application in the presence of lysozyme can be controlled
by properly selecting the chitosan to be used in the shell layer of
nanofibers. Regardless of their compositions, cross-linked nonwo-
vens displayed cytocompatibility. In addition, only structures con-
taining TH exhibited expressive antibacterial activity against a
wide range of periodontal pathogens, indicating that the antibacte-
rial activity of TH was not compromised after being loaded into the
core-sheath nanofibers and by the crosslinking process. Therefore,
the genipin-cross-linked chitosan/poly (vinyl alcohol) electrospun
core-sheath nonwovens, especially G(CH/PVA-TH), are veryPlease cite this article as: D. M. dos Santos, P. A. M. Chagas, I. S. Leite et al., C
delivery system for periodontitis treatment, International Journal of Biologicalpromising as a novel drug delivery system in periodontitis
treatment.
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